Mechanistically, EphB1 lacks detectable tyrosine phosphorylation in glioma cells and, when overexpressed, inhibits ephrin-B2-induced migration and invasion both in vitro and in vivo (Teng et al., 2013). The gene discussed is EPHB1; the disease is central nervous system cancer.